Skip to main content
Top
Published in: BMC Ophthalmology 1/2016

Open Access 01-12-2016 | Case report

Case report: Aqueous and Vitreous amino-acid concentrations in a patient with maple syrup urine disease operated on rhegmatogenous retinal detachment

Authors: Menelaos G. Kanakis, Helen Michelakakis, Petros Petrou, Chrysanthi Koutsandrea, Ilias Georgalas

Published in: BMC Ophthalmology | Issue 1/2016

Login to get access

Abstract

Background

Maple syrup urine disease (MSUD) is a rare metabolic disorder, affecting the metabolism of branched chain amino-acids (Valine, Leukine, Isoleukine). We present a rare case of rhegmatogenous retinal detachment (RRD) in a MSUD patient.

Case presentation

We performed amino acid analysis of aqueous humour, vitreous and serum samples obtained during surgery from a 24 year old female MSUD patient successfully operated on RRD.
Serum values for a-amino-butyric acid, valine, isoleucine, leucine, tyrosine, phenylalanine, ornithine and histidine were low, while values for citrulline, methionine and lysine were borderline low, all attributed to the patient’s special diet. Serum glutamate was above normal, probably due to the breakdown of glutamine to glutamate.
In the aqueous and vitreous the amino acids implicated in MSUD (Valine, Leukine Isoleukine), were within normal range. Glutamate was absent in the vitreous and presented low levels in the aqueous. Glutamate has been reported to play an important role in retinal damage. Elevated glutamate levels have been reported in vitreous specimens from patients subjected to vitrectomy or buckling surgery for RRD. In MSUD, glutamate has been implicated in the pathogenesis of brain damage. Low levels of glutamate have been observed in the cerebellum of experimental MSUD animals, as well as postmortem brain tissue from a child that died of leucine intoxication. The reduction was attributed to the elevation of a-ketoisocaproic which reverses the net direction of nitrogen flow. It could be argued that this could impact on amino acid concentration in aqueous and vitreous fluids.

Conclusions

Although no definite conclusions can be drawn by this extremely rare case, the low vitreous and aqueous levels of Glutamate is an interesting finding. Further studies are needed to provide a better insight in the role of amino acids as neurotransmitters in the human eye in health and disease.
Appendix
Available only for authorised users
Literature
1.
go back to reference Korein J, Sansaricq C, Kalmijn M, Honig J, Lange B. Maple syrup urine disease: clinical, eeg, and plasma amino acid correlations with a theoretical mechanism of acute neurotoxicity. Int J Neurosci. 1994;79:21–45.CrossRefPubMed Korein J, Sansaricq C, Kalmijn M, Honig J, Lange B. Maple syrup urine disease: clinical, eeg, and plasma amino acid correlations with a theoretical mechanism of acute neurotoxicity. Int J Neurosci. 1994;79:21–45.CrossRefPubMed
2.
go back to reference Burke JP, O’Keefe M, Bowell R, Naughten ER. Ophthalmic findings in maple syrup urine disease. Metab Pediatr Syst Ophthalmol. 1991;14:12–5. Burke JP, O’Keefe M, Bowell R, Naughten ER. Ophthalmic findings in maple syrup urine disease. Metab Pediatr Syst Ophthalmol. 1991;14:12–5.
3.
go back to reference Diederen RMH, La Heij EC, Deutz NEP, Kijlstra A, Kessels AGH, van Eijk HMH, et al. Increased glutamate levels in the vitreous of patients with retinal detachment. Exp Eye Res. 2006;83:45–50.CrossRefPubMed Diederen RMH, La Heij EC, Deutz NEP, Kijlstra A, Kessels AGH, van Eijk HMH, et al. Increased glutamate levels in the vitreous of patients with retinal detachment. Exp Eye Res. 2006;83:45–50.CrossRefPubMed
4.
go back to reference Wuu JA, Wen LY, Chuang TY, Chang GG. Amino acid concentrations in serum and aqueous humor from subjects with extreme myopia or senile cataract. Clin Chem. 1988;34:1610–3.PubMed Wuu JA, Wen LY, Chuang TY, Chang GG. Amino acid concentrations in serum and aqueous humor from subjects with extreme myopia or senile cataract. Clin Chem. 1988;34:1610–3.PubMed
5.
6.
go back to reference Wakabayashi Y, Yagihashi T, Kezuka J, Muramatsu D, Usui M, Iwasaki T. Glutamate levels in aqueous humor of patients with retinal artery occlusion. Retina. 2006;26:432–6.CrossRefPubMed Wakabayashi Y, Yagihashi T, Kezuka J, Muramatsu D, Usui M, Iwasaki T. Glutamate levels in aqueous humor of patients with retinal artery occlusion. Retina. 2006;26:432–6.CrossRefPubMed
7.
go back to reference Bertram KM, Bula DV, Pulido JS, Shippy SA, Gautam S, Lu MJ, et al. Amino-acid levels in subretinal and vitreous fluid of patients with retinal detachment. Eye. 2008;22:582–9.CrossRefPubMed Bertram KM, Bula DV, Pulido JS, Shippy SA, Gautam S, Lu MJ, et al. Amino-acid levels in subretinal and vitreous fluid of patients with retinal detachment. Eye. 2008;22:582–9.CrossRefPubMed
8.
go back to reference Honkanen RA, Baruah S, Zimmerman MB, Khanna CL, Weaver YK, Narkiewicz J, et al. Vitreous amino acid concentrations in patients with glaucoma undergoing vitrectomy. Arch Ophthalmol. 2003;121:183–8.CrossRefPubMed Honkanen RA, Baruah S, Zimmerman MB, Khanna CL, Weaver YK, Narkiewicz J, et al. Vitreous amino acid concentrations in patients with glaucoma undergoing vitrectomy. Arch Ophthalmol. 2003;121:183–8.CrossRefPubMed
9.
go back to reference Asensio Sánchez VM, Corral Azor A, Aguirre Aragón B, De Paz García M. Amino acid concentrations in the vitreous body in control subjects. Arch Soc Esp Oftalmol. 2002;77:611–6.PubMed Asensio Sánchez VM, Corral Azor A, Aguirre Aragón B, De Paz García M. Amino acid concentrations in the vitreous body in control subjects. Arch Soc Esp Oftalmol. 2002;77:611–6.PubMed
10.
go back to reference Yalcinbayir O, Buyukuysal RL, Gelisken O, Buyukuysal C, Can B. Amino acid and vascular endothelial growth factor levels in subretinal fluid in rhegmatogenous retinal detachment. Mol Vision. 2014;20:1357–65. Yalcinbayir O, Buyukuysal RL, Gelisken O, Buyukuysal C, Can B. Amino acid and vascular endothelial growth factor levels in subretinal fluid in rhegmatogenous retinal detachment. Mol Vision. 2014;20:1357–65.
11.
go back to reference Schonheyder F, Ehlers N, Hust B. Remarks on the aqueous humor/plasma ratios for amino acids and related compounds in patients with various chronic ocular disorders. Acta Ophthalmol. 1975;53:627–34.CrossRef Schonheyder F, Ehlers N, Hust B. Remarks on the aqueous humor/plasma ratios for amino acids and related compounds in patients with various chronic ocular disorders. Acta Ophthalmol. 1975;53:627–34.CrossRef
12.
go back to reference Aydemir O, Türkçüoǧlu P, Güler M, Çeliker Ü, Üstündaǧ B, Yilmaz T, et al. Plasma and vitreous homocysteine concentrations in patients with proliferative diabetic retinopathy. Retina. 2008;28:741–3.CrossRefPubMed Aydemir O, Türkçüoǧlu P, Güler M, Çeliker Ü, Üstündaǧ B, Yilmaz T, et al. Plasma and vitreous homocysteine concentrations in patients with proliferative diabetic retinopathy. Retina. 2008;28:741–3.CrossRefPubMed
13.
go back to reference Vogel KR, Arning E, Wasek BL, McPherson S, Bottiglieri T, Gibson KM. Brain–blood amino acid correlates following protein restriction in murine maple syrup urine disease. Orphanet J Rare Dis. 2014;9:73.CrossRefPubMedPubMedCentral Vogel KR, Arning E, Wasek BL, McPherson S, Bottiglieri T, Gibson KM. Brain–blood amino acid correlates following protein restriction in murine maple syrup urine disease. Orphanet J Rare Dis. 2014;9:73.CrossRefPubMedPubMedCentral
14.
go back to reference Hu RG, Lim JC, Kalloniatis M, Donaldson PJ. Cellular localization of glutamate and glutamine metabolism and transport pathways in the rat ciliary epithelium. Invest Ophthalmol Vis Sci. 2011;52:3345–53.CrossRefPubMed Hu RG, Lim JC, Kalloniatis M, Donaldson PJ. Cellular localization of glutamate and glutamine metabolism and transport pathways in the rat ciliary epithelium. Invest Ophthalmol Vis Sci. 2011;52:3345–53.CrossRefPubMed
15.
go back to reference Reddy VN, Thompson MR, Chakrapani B. Amino acid transport across blood-aqueous barrier of mammalian species. Exp Eye Res. 1977;25:555–62.CrossRefPubMed Reddy VN, Thompson MR, Chakrapani B. Amino acid transport across blood-aqueous barrier of mammalian species. Exp Eye Res. 1977;25:555–62.CrossRefPubMed
16.
go back to reference Neal MJ. Amino acid transmitter substances in the vertebrate retina. Gen Pharmacol. 1976;7:321–32.CrossRefPubMed Neal MJ. Amino acid transmitter substances in the vertebrate retina. Gen Pharmacol. 1976;7:321–32.CrossRefPubMed
17.
go back to reference Kashii S. The role of nitric oxide in the ischemic retina. Nippon Ganka Gakkai Zasshi. 1995;99:1361–76.PubMed Kashii S. The role of nitric oxide in the ischemic retina. Nippon Ganka Gakkai Zasshi. 1995;99:1361–76.PubMed
18.
go back to reference Nicholls D, Attwell D. The release and uptake of excitatory amino acids. Trends Pharmacol Sci. 1990;11:462–8.CrossRefPubMed Nicholls D, Attwell D. The release and uptake of excitatory amino acids. Trends Pharmacol Sci. 1990;11:462–8.CrossRefPubMed
19.
go back to reference Sherry DM, Townes-Anderson E. Rapid glutamatergic alterations in the neural retina induced by retinal detachment. Invest Ophthalmol Vis Sci. 2000;41:2779–90.PubMed Sherry DM, Townes-Anderson E. Rapid glutamatergic alterations in the neural retina induced by retinal detachment. Invest Ophthalmol Vis Sci. 2000;41:2779–90.PubMed
20.
go back to reference Dodd PR, Williams SH, Gundlach AL, Harper PA, Healy PJ, Dennis JA, et al. Glutamate and gamma-aminobutyric acid neurotransmitter systems in the acute phase of maple syrup urine disease and citrullinemia encephalopathies in newborn calves. J Neurochem. 1992;59:582–90.CrossRefPubMed Dodd PR, Williams SH, Gundlach AL, Harper PA, Healy PJ, Dennis JA, et al. Glutamate and gamma-aminobutyric acid neurotransmitter systems in the acute phase of maple syrup urine disease and citrullinemia encephalopathies in newborn calves. J Neurochem. 1992;59:582–90.CrossRefPubMed
21.
go back to reference Zinnanti WJ, Lazovic J, Griffin K, Skvorak KJ, Paul HS, Homanics GE, et al. Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease. Brain. 2009;132:903–18.CrossRefPubMedPubMedCentral Zinnanti WJ, Lazovic J, Griffin K, Skvorak KJ, Paul HS, Homanics GE, et al. Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease. Brain. 2009;132:903–18.CrossRefPubMedPubMedCentral
22.
go back to reference Prensky AL, Moser HW. Brain lipids, proteolipids, and free amino acids in maple syrup urine disease. J Neurochem. 1966;13:863–74.CrossRefPubMed Prensky AL, Moser HW. Brain lipids, proteolipids, and free amino acids in maple syrup urine disease. J Neurochem. 1966;13:863–74.CrossRefPubMed
23.
go back to reference Ripps H, Shen W. Review: Taurine: a “very essential” amino acid. Mol Vision. 2012;18:2673–86. Ripps H, Shen W. Review: Taurine: a “very essential” amino acid. Mol Vision. 2012;18:2673–86.
Metadata
Title
Case report: Aqueous and Vitreous amino-acid concentrations in a patient with maple syrup urine disease operated on rhegmatogenous retinal detachment
Authors
Menelaos G. Kanakis
Helen Michelakakis
Petros Petrou
Chrysanthi Koutsandrea
Ilias Georgalas
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Ophthalmology / Issue 1/2016
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-016-0349-3

Other articles of this Issue 1/2016

BMC Ophthalmology 1/2016 Go to the issue